[425] Sonnet BioTherapeutics Holdings, Inc. Business Combination Communication

Filing Impact

(High)

Filing Sentiment

(Neutral)

Form Type

425

Rhea-AI Filing Summary

Analyzing...

11/12/2025 - 09:39 AM

Source: View Original Filing on SEC EDGAR

Sonnet Biotherapeutc Hldng Inc

NASDAQ:SONN

SONN Rankings

#6444 Ranked by Market Cap

N/A Ranked by Dividends

SONN Latest News

Dec 2, 2025

Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination

Dec 2, 2025

Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc

Nov 18, 2025

Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting

Sep 19, 2025

Sonnet to Present at the MedInvest Biotech & Pharma Conference

Aug 11, 2025

Sonnet Releases Virtual Investor "What This Means" Segment

SONN Latest SEC Filings

Dec 3, 2025

[Form 4] Sonnet BioTherapeutics Holdings, Inc. Insider Trading Activity

Dec 17, 2025

[EFFECT] Sonnet BioTherapeutics Holdings, Inc. SEC Filing

Dec 17, 2025

[EFFECT] Sonnet BioTherapeutics Holdings, Inc. SEC Filing

Dec 17, 2025

[EFFECT] Sonnet BioTherapeutics Holdings, Inc. SEC Filing

Dec 17, 2025

[EFFECT] Sonnet BioTherapeutics Holdings, Inc. SEC Filing

SONN Stock Data

Market Cap 8.60M

Float 6.80M

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City PRINCETON